Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP566922.RAvHGXV29N_3nNqacM1kAZC8L-EOFL_RL8u4NEv8BFeIw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP566922.RAvHGXV29N_3nNqacM1kAZC8L-EOFL_RL8u4NEv8BFeIw130_assertion type Assertion NP566922.RAvHGXV29N_3nNqacM1kAZC8L-EOFL_RL8u4NEv8BFeIw130_head.
- NP566922.RAvHGXV29N_3nNqacM1kAZC8L-EOFL_RL8u4NEv8BFeIw130_assertion description "[CD200 is expressed in nearly all precursor B-lymphoblastic leukemias, with aberrant overexpression or underexpression compared with normal B-cell progenitors in 55% of cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566922.RAvHGXV29N_3nNqacM1kAZC8L-EOFL_RL8u4NEv8BFeIw130_provenance.
- NP566922.RAvHGXV29N_3nNqacM1kAZC8L-EOFL_RL8u4NEv8BFeIw130_assertion evidence source_evidence_literature NP566922.RAvHGXV29N_3nNqacM1kAZC8L-EOFL_RL8u4NEv8BFeIw130_provenance.
- NP566922.RAvHGXV29N_3nNqacM1kAZC8L-EOFL_RL8u4NEv8BFeIw130_assertion SIO_000772 22180482 NP566922.RAvHGXV29N_3nNqacM1kAZC8L-EOFL_RL8u4NEv8BFeIw130_provenance.
- NP566922.RAvHGXV29N_3nNqacM1kAZC8L-EOFL_RL8u4NEv8BFeIw130_assertion wasDerivedFrom befree-20150227 NP566922.RAvHGXV29N_3nNqacM1kAZC8L-EOFL_RL8u4NEv8BFeIw130_provenance.
- NP566922.RAvHGXV29N_3nNqacM1kAZC8L-EOFL_RL8u4NEv8BFeIw130_assertion wasGeneratedBy ECO_0000203 NP566922.RAvHGXV29N_3nNqacM1kAZC8L-EOFL_RL8u4NEv8BFeIw130_provenance.